SEC Filing Analysis: GLOBUS MEDICAL INC (GMED)

Executive Summary

• Trading Significance: Low
• Key Takeaway: A director has filed a notice of intent for a minor, pre-planned stock sale, representing a negligible fraction of the company's market value.
• Market Impact: The transaction is too small to have any meaningful impact on the stock's price or trading volume.

Company Information

Field	Value
Company	GLOBUS MEDICAL INC
Ticker Symbol	GMED
CIK	0001237831
Industry	Surgical & Medical Instruments & Apparatus

Insider Information

Field	Value
Name	RHOADS ANN D
CIK	0001250252
Title/Position	Director
Relationship	Director

Transaction Details

Field	Value
Form Type	144
Transaction Date	2025-11-10 (Approximate Sale Date)
Transaction Code	S (Proposed Sale)
Security Type	Common
Shares Involved	2,000
Price Per Share	$85.00
Total Value	$170,000.00
Shares Owned After	Not Stated
Ownership Type	Not Stated

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$170,000.00
% of Market Cap	0.0015%
Shares Transacted	2,000
% of Shares Outstanding	0.0015%
Post-Transaction Ownership	Not Stated
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: For a company with an $11.23 billion market capitalization, a $170,000 transaction is financially insignificant.
• Transaction Significance: The sale represents a minuscule percentage of both market capitalization and shares outstanding, indicating it is likely for personal liquidity or portfolio management rather than a change in outlook on the company.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The sale is immaterial in size. Furthermore, it is being conducted under a 10b5-1 plan adopted on November 8, 2024, which means the decision to sell was made well in advance and is not based on current, non-public information.

Volume & Sentiment

• Expected Volume Impact: Negligible. The 2,000 shares are unlikely to be noticeable against the stock's typical daily trading volume.
• Sentiment Indicator: Neutral. Pre-planned, small sales by directors are routine and do not typically influence market sentiment.

Additional Context

Transaction Notes

• Special Circumstances: This notice of proposed sale was filed pursuant to a Rule 10b5-1 trading plan, indicating it is an automated, pre-scheduled transaction.
• Recent Activity: The filing notes the insider has been selling shares recently, including 8,000 shares on November 7, 2025, and 10,000 shares on September 15, 2025, suggesting a consistent, planned liquidation schedule.